Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
3 Audio Video Stocks to Watch as Industry Witnesses Headwinds
Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics
Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First
Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Conference Transcript
Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcript
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
Dolby and rednote Bring More Immersive Storytelling to Video Content with Dolby Atmos
Dolby Recognized as 2025 Supplier of the Year and Overdrive Award Winner by General Motors
Dolby Laboratories to Present at Upcoming Investor Conferences
SONY's Q4 Earnings Plunge Y/Y Despite Healthy Revenues, G&NS Weakens
Dolby: I Don't Mind Waiting In 2026
Why Dolby Labs Stock Crashed Today
Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y
Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript
Compared to Estimates, Dolby Laboratories (DLB) Q2 Earnings: A Look at Key Metrics
Dolby Laboratories (DLB) Q2 Earnings and Revenues Top Estimates
Dolby Laboratories Reports Second Quarter 2026 Financial Results
Dolby Laboratories (NYSE:DLB) Receives Average Rating of “Moderate Buy” from Analysts
Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2026 Financial Results
Dolby Labs Has Easy 30% Upside
Dolby Laboratories (NYSE:DLB) Receives $90.75 Average Target Price from Analysts
Dolby Laboratories (NYSE:DLB) Reaches New 52-Week Low – What’s Next?
Dolby Named to Fast Company's Annual List of the World's Most Innovative Companies List for Fourth Time
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod's Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer's Disease Co-Pathology
3 Audio Video Stocks to Buy as Industry Tailwinds Gain Momentum
4 Consumer Discretionary Stocks to Grab as Inflation Continues to Ease
Dynamic Technology Lab Private Ltd Has $274,000 Stock Holdings in Dolby Laboratories $DLB
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
5 Solid Discretionary Stocks to Grab as Consumer Confidence Rebounds
Dolby Laboratories $DLB Shares Sold by Envestnet Asset Management Inc.
Wall Street Analysts Predict a 40.22% Upside in Dolby Laboratories (DLB): Here's What You Should Know
4 Consumer Discretionary Stocks to Buy as Inflation Continues to Cool
Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential
Consumer Sentiment Hits 6-Month High: 4 Discretionary Stocks to Buy
Source-Connect 4 Becomes First metadata-connected Dolby® Atmos remote review & approval tool
How Much Upside is Left in Dolby Laboratories (DLB)? Wall Street Analysts Think 39.04%
Dolby's Q1 Earnings & Revenues Surpass Estimates, Fall Y/Y, Stock Down
Bank of New York Mellon Corp Sells 35,447 Shares of Dolby Laboratories $DLB
Dolby Laboratories: Solid Q1 Earnings, Valuation Has Improved (Rating Upgrade)
Dolby Laboratories, Inc. (DLB) Q1 2026 Earnings Call Transcript
Dolby Laboratories (DLB) Reports Q1 Earnings: What Key Metrics Have to Say
Dolby Laboratories (DLB) Q1 Earnings and Revenues Surpass Estimates
Dolby Laboratories Reports First Quarter 2026 Financial Results
Wall Street's Insights Into Key Metrics Ahead of Dolby Laboratories (DLB) Q1 Earnings
Dolby Laboratories (NYSE:DLB) Reaches New 52-Week Low Following Analyst Downgrade
Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results
Will Dolby Laboratories (DLB) Beat Estimates Again in Its Next Earnings Report?
Dolby Sets the New Standard for Premium Entertainment at CES 2026